These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8571621)

  • 1. Stark self-referral rules burdened with complexities.
    Barratt K; Katayama A
    Wis Med J; 1995 Dec; 94(12):697-701. PubMed ID: 8571621
    [No Abstract]   [Full Text] [Related]  

  • 2. Physician refer thyself: is Stark II, phase III the final voyage?
    Manchikanti L; McMahon EB
    Pain Physician; 2007 Nov; 10(6):725-41. PubMed ID: 17987094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stark II Final Rule (Phase I): some answers, more questions.
    Shay AW; Murphy SL
    Manag Care Q; 2002; 10(1):38-46. PubMed ID: 15988954
    [No Abstract]   [Full Text] [Related]  

  • 4. Examining the impact of the new Stark rules on joint ventures.
    Washlick JR
    Healthc Financ Manage; 2008 Nov; 62(11):48-52. PubMed ID: 18990836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stark II: the quagmire thickens.
    Ivers D
    J Ark Med Soc; 1998 Jul; 95(2):75-8. PubMed ID: 9676062
    [No Abstract]   [Full Text] [Related]  

  • 6. "Stark" reality: self-referral rule holds risk and opportunity.
    Lebowitz PH
    Radiol Manage; 2001; 23(5):34-9. PubMed ID: 11680255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stark II proposed regulations. Impacting group practices and physician employers.
    Wachler AB; Avery PA
    Mich Health Hosp; 1998; 34(3):37-8. PubMed ID: 10179373
    [No Abstract]   [Full Text] [Related]  

  • 8. The Stark truth about the Stark law: Part II.
    Gosfield AG
    Fam Pract Manag; 2004 Feb; 11(2):41-5. PubMed ID: 15011481
    [No Abstract]   [Full Text] [Related]  

  • 9. Physician group practice implications under the proposed Stark II regulations.
    Sokolow DS
    Health Care Law Mon; 1999 Aug; ():6-9. PubMed ID: 10661984
    [No Abstract]   [Full Text] [Related]  

  • 10. Stark rules. Purchases that pass muster.
    Terry K
    Med Econ; 2006 Dec; 83(24):44-6, 49. PubMed ID: 17249392
    [No Abstract]   [Full Text] [Related]  

  • 11. New Stark II rules on referrals will further restrict medical practices.
    Caesar N
    Manag Care; 1997 May; 6(5):96-8. PubMed ID: 10168642
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes to the federal Stark law that affect diagnostic imaging arrangements.
    Stirewalt K
    Minn Med; 2009 Dec; 92(12):49-51. PubMed ID: 20092174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are you missing out on a valuable profit center?
    Jahn M
    Med Econ; 1997 Jan; 74(1):115-6, 119-22. PubMed ID: 10164326
    [No Abstract]   [Full Text] [Related]  

  • 14. The Stark regulations: so much text; so little substance.
    Conn L; Weissburg C
    Health Syst Rev; 1995; 28(6):25-7, 53-4. PubMed ID: 10153032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How the new Stark II regulations affect group practices.
    Larios D; Meyer A
    Tenn Med; 1998 Apr; 91(4):128-30. PubMed ID: 9564245
    [No Abstract]   [Full Text] [Related]  

  • 16. HCFA issues. Stark II proposed rules.
    Portman RM; Lisa GC
    Bull Am Coll Surg; 1998 Jun; 83(6):20-23. PubMed ID: 10180259
    [No Abstract]   [Full Text] [Related]  

  • 17. The new Stark rules: what does Stark II Phase III mean for healthcare providers?
    Hofstra PS; Bilimoria NM
    J Med Pract Manage; 2008; 23(5):300-3. PubMed ID: 18472609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PHOs, IPAs members must comply with Stark regs.
    Manag Care Strateg; 1998 Dec; 6(12):142-4. PubMed ID: 10351379
    [No Abstract]   [Full Text] [Related]  

  • 19. Proposed Stark II rules: clarification or more confusion?
    Shay A; Francesconi G
    J Health Hosp Law; 1998 Jun; 31(2):95-113. PubMed ID: 10186240
    [No Abstract]   [Full Text] [Related]  

  • 20. How the new Stark rules affect you.
    Guglielmo WJ
    Med Econ; 2008 Feb; 85(3):39-42. PubMed ID: 18314820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.